These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neutrophils as regulators of cardiovascular inflammation. Silvestre-Roig C; Braster Q; Ortega-Gomez A; Soehnlein O Nat Rev Cardiol; 2020 Jun; 17(6):327-340. PubMed ID: 31996800 [TBL] [Abstract][Full Text] [Related]
4. Update on the role of neutrophils in atherosclerotic plaque vulnerability. Carbone F; Mach F; Montecucco F Curr Drug Targets; 2015; 16(4):321-33. PubMed ID: 25382205 [TBL] [Abstract][Full Text] [Related]
5. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases. Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265 [TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders. Henning RJ; Bourgeois M; Harbison RD Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072 [TBL] [Abstract][Full Text] [Related]
7. Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases. Fu H; Ni M; Chen JK; Zhao T; Deng YP; Li DJ; Jiang GJ; Shen FM Curr Drug Targets; 2017; 18(15):1779-1784. PubMed ID: 26302792 [TBL] [Abstract][Full Text] [Related]
8. Fine-tuning neutrophil activation: Strategies and consequences. van der Linden M; Meyaard L Immunol Lett; 2016 Oct; 178():3-9. PubMed ID: 27262927 [TBL] [Abstract][Full Text] [Related]
9. Phenotypes and functions of "aged" neutrophils in cardiovascular diseases. Ling S; Xu JW Biomed Pharmacother; 2024 Oct; 179():117324. PubMed ID: 39216451 [TBL] [Abstract][Full Text] [Related]
10. Neutrophil's weapons in atherosclerosis. Chistiakov DA; Bobryshev YV; Orekhov AN Exp Mol Pathol; 2015 Dec; 99(3):663-71. PubMed ID: 26551083 [TBL] [Abstract][Full Text] [Related]
11. An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. Maugeri N; Rovere-Querini P; Evangelista V; Godino C; Demetrio M; Baldini M; Figini F; Coppi G; Slavich M; Camera M; Bartorelli A; Marenzi G; Campana L; Baldissera E; Sabbadini MG; Cianflone D; Tremoli E; D'Angelo A; Manfredi AA; Maseri A PLoS One; 2012; 7(6):e39484. PubMed ID: 22761804 [TBL] [Abstract][Full Text] [Related]
16. CXC chemokine KC fails to induce neutrophil infiltration and neoangiogenesis in a mouse model of myocardial infarction. Oral H; Kanzler I; Tuchscheerer N; Curaj A; Simsekyilmaz S; Sönmez TT; Radu E; Postea O; Weber C; Schuh A; Liehn EA J Mol Cell Cardiol; 2013 Jul; 60():1-7. PubMed ID: 23598282 [TBL] [Abstract][Full Text] [Related]
17. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326 [TBL] [Abstract][Full Text] [Related]
18. Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. de Boer OJ; Li X; Teeling P; Mackaay C; Ploegmakers HJ; van der Loos CM; Daemen MJ; de Winter RJ; van der Wal AC Thromb Haemost; 2013 Feb; 109(2):290-7. PubMed ID: 23238559 [TBL] [Abstract][Full Text] [Related]